Key facts
- Ambiorix (Monitoring Equipment)’s last known valuation is $2.5M (Dec 2025).
- It has raised $210K; the latest was Angel (individual) ($210K) in Dec 2025.
- Notable investors include Start It X.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ambiorix (Monitoring Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Ambiorix (Monitoring Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ambiorix (Monitoring Equipment)
Developer of an electrocardiogram monitoring device designed to observe cardiac activity. The company offers continuous electrocardiogram data collection over an extended period, enabling individuals to analyze their heart rhythm in their home environment.
- Sector
- Healthcare
- HQ
- Leuven, Belgium
- Founded
- 2024
- Employees
- 8
- Website
- ambiorix.com/
- Ownership
- Privately Held (backing)
Ambiorix (Monitoring Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ambiorix (Monitoring Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ambiorix (Monitoring Equipment) in its N-PORT filings yet. We sweep new filings monthly.